LS Investment Advisors’s Genomic Health, Inc. GHDX Stock Holding History

LS Investment Advisors’s Portfolio GHDX Stock Details GHDX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q4	–	Sell	-706	Closed	-$48K	–	1751
2019 Q3	$48K	Buy	+706	New	+$48.5K	﹤0.01%	1316

LS Investment Advisors's GHDX Position: Q4 2019 in Review

LS Investment Advisors sold out of Genomic Health, Inc. (GHDX) in Q4 2019, closing a stake of 706 shares — an estimated $48K sold.

LS Investment Advisors first reported a position in GHDX in Q3 2019 and held it in 1 quarter. The position peaked at $48K in Q3 2019. 0 funds tracked by Wall St. Rank hold GHDX as of Q4 2019.

LS Investment Advisors reported no remaining Genomic Health, Inc. position as of Q4 2019 after selling out during the quarter.
LS Investment Advisors sold 706 Genomic Health, Inc. shares in Q4 2019, an estimated $48K.
LS Investment Advisors first reported a position in Genomic Health, Inc. in Q3 2019 and held it in 1 quarter.
LS Investment Advisors's Genomic Health, Inc. position peaked at $48K in Q3 2019.
0 funds tracked by Wall St. Rank held Genomic Health, Inc. as of Q4 2019.

Based on LS Investment Advisors's 13F filing for Q4 2019, filed 31 Jan 2020.